Stephen Saad
Fortuna: 525 M $ al 31/05/2026
Fortuna: 525 M $ al 31/05/2026
Stephen Bradley Saad fundó Aspen Pharmacare Holdings Ltd. El Sr. Saad es presidente de The Sharks Pty Ltd. y director general del grupo y director ejecutivo de Aspen Pharmacare Holdings Ltd.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2025 | 58.797.851 ( 13,18 % ) | 525 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ASPEN PHARMACARE HOLDINGS LIMITED | Fundador | - |
The Sharks Pty Ltd. | Presidente | - |
Aspen Oss BV
Aspen Oss BV Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals products | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
Aspen Pharma Pty Ltd.
Aspen Pharma Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Aspen Pharmacare Holdings Ltd.
Aspen Pharmacare Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals products | Health Technology |
The Sharks Pty Ltd. | |
Aspen Oss BV
Aspen Oss BV Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals products | Health Technology |
Aspen Pharma Pty Ltd.
Aspen Pharma Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.